Low CD3 level is a risk factor for amyotrophic lateral sclerosis: a Mendelian randomization study

Area of Science:

• Immunology
• Neuroscience
• Genetics

Background:

• Amyotrophic Lateral Sclerosis (ALS) is a fatal neurodegenerative disease linked to immune system dysfunction.
• Identifying immune system links to ALS is crucial for developing new therapeutic strategies.

Purpose of the Study:

• To investigate the causal relationship between immune cell traits and ALS using Mendelian randomization.
• To identify specific immune markers associated with ALS risk.

Main Methods:

• Mendelian randomization analysis of 731 immune cell traits in European populations.
• Colocalization analysis to confirm causality.
• Protein-protein interaction prediction to identify interacting proteins.

Main Results:

• Reduced expression of CD3 on central memory CD8+ T cells was identified as a significant risk factor for ALS (OR = 0.90, P < 0.00003).
• CD3 was found to interact with VCP, HLA-DRA, and HLA-DRB5, proteins implicated in ALS and adaptive immunity.

Conclusions:

• Low CD3 expression on specific T cells represents a novel risk factor for ALS.
• The identified interactions suggest a potential mechanism involving adaptive immune response in ALS pathogenesis.
• These findings may offer new diagnostic and therapeutic targets for ALS.